|
|
This issue sponsored by the Northeast Lipid Association
Featuring: "New Pharmacologic Approaches to Obesity" and "The Adipocyte: Friend or Foe?"
|
|
|
This issue sponsored by the Southeast Lipid Association
Featuring: "An Update on Statin Safety with an Emphasis on Differences” and “Managing the Statin-Intolerant Patient: Low-Dose/Low-Frequency Treatment Regimens"
|
|
|
This issue sponsored by the Southwest Lipid Association
Featuring: "Physical Findings for the Lipidologist, Translating Physical Studies of Lipoproteins into Clinical Lipidology" and "Not So Specific Findings of an Unusual Lipid Disorder"
|
|
|
This issue sponsored by the Pacific Lipid Association
Featuring: "HDL-P vs. ApoA1 vs. HDL-C" in Context of the HDL-Hypothesis Controversy
The Role of Remnant Lipoproteins in Atherogenesis
|
|
|
This issue sponsored by the Midwest Lipid Association
Featuring: Diabetes Optimal Care and Cardiovascular Risk Reduction (DOC-CARE); Pediatric FH Guidelines for the Adult Lipidologist
|
|
|
This issue sponsored by the Northeast Lipid Association
Coping with Statin Adverse Events—Focus on Pharmacokinetics and Pharmacodynamics
Primary Hypertriglyceridemia—Treating Triglycerides When It’s Not the Usual Suspects
|
.jpg)
.png)
(1).png)
